Climate Change as a Significant Global Challenge: Pathways to Civil Discourse
International Journal for Peace and Public Leadership · 2025
DOI: 10.63470/oyrr8376 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal for Peace and Public Leadership, 2025. Verfasst von James Fleming.
Abstract (Originalsprache)
Climate change is widely recognized as a pressing global challenge. While it is commonly framed as a scientific and environmental issue, its complexity extends far beyond atmospheric carbon dioxide concentrations and international treaties. Climate change is deeply rooted in historical, political, and humanitarian contexts, necessitating a broader, interdisciplinary approach. Despite its significance, public discourse surrounding climate change remains polarized and contentious, often driven by media sensationalism. This paper seeks to illuminate the historical and cultural dimensions of climate change discourse, linking contemporary concerns with longstanding environmental apprehensions. By drawing on the history of environmental determinism and climate-related anxieties, it offers a more nuanced understanding of the factors shaping today’s debates. The goal is to move beyond ideological entrenchment and cultivate a more constructive, informed, and balanced conversation, aimed at establishing pathways to civil discourse, better cooperation, and responsible environmental stewardship.
Zitieren
APA
Fleming, J. (2025). Climate Change as a Significant Global Challenge: Pathways to Civil Discourse. International Journal for Peace and Public Leadership. https://doi.org/10.63470/oyrr8376
Vancouver
Fleming J. Climate Change as a Significant Global Challenge: Pathways to Civil Discourse. International Journal for Peace and Public Leadership. 2025. doi:10.63470/oyrr8376
BibTeX
@article{Fleming2025,
author = {Fleming, James},
title = {Climate Change as a Significant Global Challenge: Pathways to Civil Discourse},
journal = {International Journal for Peace and Public Leadership},
year = {2025},
doi = {10.63470/oyrr8376}
}
EUVIMED